`
`Page 1 of 1
`
`FDA Home3 Developing Products for Rare Diseases & Conditions4
`
`Search Orphan Drug Designations and Approvals
`Results for All Designations
`Return to Orphan Designation Search Page
`Generic
`Designation
`Row
`Num
`Name
`Date
`
`Orphan Designation
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`lenalidomide
`
`04-29-2015
`
`Treatment of extranodal marginal zone lymphoma of mucosa-
`associated lymphoid tissue
`
`lenalidomide
`
`01-17-2007
`
`Treatment of chronic lymphocytic leukemia
`
`lenalidomide
`
`09-17-2013
`
`Treatment of follicular lymphoma
`
`lenalidomide
`
`03-28-2011
`
`Treatment of diffuse large B-cell lymphoma
`
`lenalidomide
`
`04-27-2009
`
`Treatment of mantle cell lymphoma
`
`lenalidomide
`
`09-20-2001
`
`Treatment of multiple myeloma
`
`lenalidomide
`
`01-29-2004
`
`Treatment of myelodysplastic syndromes
`
`Links on this page:
`
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`2. http://www.addthis.com/bookmark.php
`
`3. http://www.fda.gov/default.htm
`
`4. http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/default.htm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers
`and Players.
`
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency
`Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`Links on this page:
`
`http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm
`
`Page 1 of 1
`
`CELGENE EXHIBIT 2019
`Coalition for Affordable Drugs VI LLC (Petitioner) v. Celgene Corporation (Patent Owner)
`Case IPR2015-01103